Literature DB >> 26986677

Medical Marijuana Use in Oncology: A Review.

Gianna Wilkie1, Bachir Sakr2, Tina Rizack2.   

Abstract

IMPORTANCE: Medicinal marijuana use is currently legal in 23 states and the District of Columbia. As more states approve marijuana use for medical indications, physicians will be asked by their patients for more information regarding the risks and benefits of use. This article reviews the history, adverse effects, and proposed mechanisms of action of marijuana and summarizes the available literature regarding symptom relief and therapeutic value in patients with cancer. OBSERVATIONS: Marijuana in oncology may have potential for use as an antiemetic, for refractory cancer pain, and as an antitumor agent. However, much of the data are based on animal data, small trials, or are outdated. CONCLUSIONS AND RELEVANCE: More research is needed in all areas related to the therapeutic use of marijuana in oncology.

Entities:  

Year:  2016        PMID： 26986677     DOI： 10.1001/jamaoncol.2016.0155

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


  25 in total

1.  Cannabis for Chronic Pain: Not Ready for Prime Time.

Authors:  Daniel Carr; Michael Schatman
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

2.  Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.

Authors:  Chao Liu; Sayed H Sadat; Koji Ebisumoto; Akihiro Sakai; Bharat A Panuganti; Shuling Ren; Yusuke Goto; Sunny Haft; Takahito Fukusumi; Mizuo Ando; Yuki Saito; Theresa Guo; Pablo Tamayo; Huwate Yeerna; William Kim; Jacqueline Hubbard; Andrew B Sharabi; J Silvio Gutkind; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2020-01-13       Impact factor: 12.531

3.  Provider Perspectives on Use of Medical Marijuana in Children With Cancer.

Authors:  Prasanna Ananth; Clement Ma; Hasan Al-Sayegh; Leah Kroon; Victoria Klein; Claire Wharton; Elise Hallez; Ilana Braun; Kelly Michelson; Abby R Rosenberg; Wendy London; Joanne Wolfe
Journal:  Pediatrics       Date:  2017-12-12       Impact factor: 7.124

Review 4.  Should Oncologists Recommend Cannabis?

Authors:  Donald I Abrams
Journal:  Curr Treat Options Oncol       Date:  2019-06-03

Review 5.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

6.  The role of cancer in marijuana and prescription opioid use in the United States: A population-based analysis from 2005 to 2014.

Authors:  Kathryn R Tringale; Minh-Phuong Huynh-Le; Mia Salans; Deborah C Marshall; Yuyan Shi; Jona A Hattangadi-Gluth
Journal:  Cancer       Date:  2019-04-22       Impact factor: 6.860

Review 7.  A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety.

Authors:  Grant Steele; Tom Arneson; Dylan Zylla
Journal:  Curr Oncol Rep       Date:  2019-02-01       Impact factor: 5.075

8.  Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample.

Authors:  Elizabeth K Do; Albert J Ksinan; Sunny Jung Kim; Egidio G Del Fabbro; Bernard F Fuemmeler
Journal:  Cancer       Date:  2021-07-20       Impact factor: 6.860

9.  Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer.

Authors:  Cong-Kai Luo; Pei-Hsuan Chou; Shang-Kok Ng; Wen-Yen Lin; Tzu-Tang Wei
Journal:  Cancer Gene Ther       Date:  2021-05-18       Impact factor: 5.987

Review 10.  The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer.

Authors:  Janet Hardy; Mellar P Davis
Journal:  Curr Treat Options Oncol       Date:  2021-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.